한글목차

세포 치료용 인체 원료 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 33억 6,000만 달러에서 2026년에는 40억 3,000만 달러로, CAGR 19.8%로 성장할 것으로 예상됩니다. 지난 수년간의 성장은 줄기세포 치료의 조기 도입, 학술적 세포 치료 연구의 확대, 세포 기반 치료의 임상시험 증가, 인체 유래 생물학적 물질의 가용성 향상, 재생의료 연구에 대한 투자 증가 등이 주요 요인으로 꼽힙니다.

세포 치료용 인체 원료 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 77억 1,000만 달러에 달하고, CAGR은 17.6%를 기록할 전망입니다. 예측 기간 동안 성장 요인으로는 승인된 세포 치료제 제품의 급증, 동종 이식 및 자가 이식 요법에 대한 수요 증가, 원료 품질에 대한 규제 당국의 감시 강화, 상업적 규모의 세포 치료제 제조 확대, 종양학에 초점을 맞춘 세포 치료제의 성장 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 이종 유래 성분이 없는 원료 및 인체 유래 원료에 대한 수요 증가, GMP 등급 및 임상 등급 원료에 대한 중요성 증가, 인체 세포 조달 및 가공 표준화의 진전, 첨단 세포 치료의 원료 요구 사항 확대, 중요 인체 원료의 장기 공급 계약 등이 있습니다.

재생의료의 활용 확대는 세포 치료용 인체유래물 시장을 견인할 것으로 예상됩니다. 재생의료는 줄기세포, 유전자 치료, 조직공학, 기타 생물학적 과정을 통해 손상된 조직이나 장기를 복구, 대체, 재생하여 정상적인 기능을 회복시키는 치료전략을 말합니다. 생명공학 기술의 발전, 세포 과정에 대한 깊은 이해, 맞춤형 치료에 대한 관심 증가, 미충족 수요에 대한 해결책으로 인해 그 채택이 급증하고 있습니다. 세포 치료용 인체 원료 시장은 일관되고 강력하며 신뢰할 수 있는 세포 기반 치료법을 만드는 데 필요한 주요 생물학적 물질을 제공함으로써 재생의료를 뒷받침하고 있습니다. 예를 들어, 2023년 8월 미국 비영리단체 '재생의료연합'이 발표한 자료에 따르면, 2023년 1분기 전 세계 세포-유전자-조직공학 치료제 개발 기업 수는 2,760개사로 2022년 1분기 1,369개사 대비 101% 증가하였습니다. 이처럼 재생의료의 보급 확대가 세포 치료용 인체유래물 시장을 견인하고 있습니다.

세포 치료용 인체 원료 시장의 주요 기업들은 세포 치료제 개발을 가속화하기 위해 화학적으로 정의된 세포배양 배지 개발에 더욱 집중하고 있습니다. 세포배양 배지는 세포가 자연환경과 분리된 시험관 내에서 증식하는 데 필요한 영양소, 성장인자, 통제된 환경조건을 제공하는 영양이 풍부한 용액 역할을 합니다. 예를 들어, 2023년 5월 스위스에 본사를 둔 헬스케어 제조 기업 론자 그룹(Lonza Group AG)은 'TheraPEAK T-VIVO 세포배양 배지'를 발표했습니다. 이 제품은 화학적으로 정의된 무혈청 및 무동물성 성분의 배합, 재조합 단백질, 세포배양 및 증식 강화 지원, 적용 지침을 제공하여 세포 치료제 제조의 일관성, 안전성 및 규제 준수를 촉진합니다. 이 배지는 동물 유래 성분의 배제, 화학적으로 정의된 구성, 규제 준수 기능을 통해 중요한 기술적 진보를 보여줌으로써 궁극적으로 안전성, 품질 및 규정 준수 향상에 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cell therapy human raw materials consist of biological substances sourced from humans, including cells, tissues, and blood components. These serve as essential building blocks in developing and producing cell-based therapeutic products. They play roles across multiple phases of cell therapy manufacturing to develop treatments for conditions like cancer, genetic disorders, and degenerative diseases.

The primary product categories for human raw materials in cell therapy include cell culture media, cell culture serum, cell culture supplements, reagents and buffers, and others. Cell culture media consist of solutions that supply nutrients and create an environment for cell growth outside their natural habitat, which is vital for laboratory-based cell research. These products support diverse cell therapies, such as dendritic cell therapy, natural killer (NK) cell therapy, stem cell therapy, and T-cell therapy, serving end users like biopharmaceutical and pharmaceutical companies, contract research organizations (CROs), and contract manufacturing organizations (CMOs), along with academic and research institutions.

Tariffs have affected the cell therapy human raw materials market by increasing the cost of imported human serum, specialized supplements, reagents, and cryoprotectants essential for cell therapy manufacturing. these impacts have been most significant across cell culture media and supplement segments, particularly in north america and europe where reliance on globally sourced human-derived materials is high. asia-pacific manufacturers have faced procurement delays due to cross-border compliance and customs requirements. however, tariffs have encouraged local sourcing of human raw materials and strengthened domestic donor networks, supporting supply chain resilience and regulatory alignment.

The cell therapy human raw materials market research report is one of a series of new reports from The Business Research Company that provides cell therapy human raw materials market statistics, including cell therapy human raw materials industry global market size, regional shares, competitors with a cell therapy human raw materials market share, detailed cell therapy human raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy human raw materials industry. This cell therapy human raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy human raw materials market size has grown rapidly in recent years. It will grow from $3.36 billion in 2025 to $4.03 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to early adoption of stem cell therapies, expansion of academic cell therapy research, growth in clinical trials for cell-based treatments, increasing availability of human-derived biological materials, rising investment in regenerative medicine research.

The cell therapy human raw materials market size is expected to see rapid growth in the next few years. It will grow to $7.71 billion in 2030 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to surge in approved cell therapy products, rising demand for allogeneic and autologous therapies, increasing regulatory scrutiny on raw material quality, expansion of commercial-scale cell therapy manufacturing, growth of oncology-focused cell therapies. Major trends in the forecast period include rising demand for xeno-free and human-derived raw materials, increasing emphasis on gmp-grade and clinical-grade inputs, growing standardization of human cell sourcing and processing, expansion of raw material requirements for advanced cell therapies, long-term supply agreements for critical human raw materials.

The growing use of regenerative medicine is poised to propel the cell therapy human raw materials market forward. Regenerative medicine encompasses therapeutic strategies that repair, replace, or regenerate impaired tissues and organs through stem cells, gene therapy, tissue engineering, or other biological processes to restore typical function. Its adoption is surging thanks to progress in biotechnology, deeper insights into cellular processes, rising interest in personalized treatments, and solutions for unmet clinical needs. The cell therapy human raw materials market bolsters regenerative medicine by providing key biological materials needed to create consistent, potent, and dependable cell-based therapies. For example, in August 2023, the Alliance for Regenerative Medicine-a US-based nonprofit-reported 2,760 developers of cell, gene, and tissue-engineering therapies worldwide in Q1 2023, a 101% increase from 1,369 in Q1 2022. Thus, the expanding adoption of regenerative medicine is fueling the cell therapy human raw materials market.

Major companies in the cell therapy human raw materials market are placing greater emphasis on creating chemically defined cell culture media to speed up cell therapy development. A cell culture medium serves as a nutrient-rich solution that supplies vital nutrients, growth factors, and controlled environmental conditions required for cells to grow and multiply in vitro, away from their natural setting. For example, in May 2023, Lonza Group AG-a Switzerland-based healthcare manufacturing firm-introduced TheraPEAK T-VIVO Cell Culture Medium. This product offers a chemically defined, serum-free, and animal component-free formula, along with recombinant proteins, better support for cell culture and expansion, and application guidance, all of which promote consistency, safety, and adherence to regulations in cell therapy production. This medium marks key technological progress through its removal of animal-derived components, chemically defined makeup, and regulatory-compliant features, ultimately boosting safety, quality, and compliance.

In July 2025, Sartorius AG, a Germany-based life science group, acquired MatTek Corp for an undisclosed sum. Through this deal, Sartorius seeks to broaden its cell technology offerings by incorporating MatTek's sophisticated human cell-based microtissue models into its Lab Products & Services division, thus enhancing its drug development platform. MatTek Corporation, a US-based biotechnology firm, focuses on creating 3D microtissue models and primary cells that better replicate human tissue structure, providing more reliable, economical, and ethical options compared to conventional 2D cultures.

Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec, Bio-Techne Corporation, STEMCELL Technologies, PromoCell GmbH, AllCells LLC, BioIVT LLC, ACROBiosystems, Sartorius CellGenix GmbH, RoosterBio Inc., Takara Bio Inc., Grifols S.A., Charles River Laboratories, WuXi AppTec, Catalent Inc., Fujifilm Cellular Dynamics Inc., Orgenesis Inc.

North America was the largest region in the cell therapy human raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy human raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell therapy human raw materials market consists of sales of primary cells, stem cell banks, tissue scaffolds, cryopreservation media, cell separation products, and extracellular matrices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Human Raw Materials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell therapy human raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy human raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy human raw materials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Cell Culture Media; Cell Culture Sera; Cell Culture Supplements; Reagents And Buffers; Other Raw Materials
• 2) By Type Of Cell Therapy: Dendritic Cell Therapy; Natural Killer (NK) Cell Therapy; Stem Cell Therapy; T-Cell Therapy
• 3) By End-Use: Biopharmaceutical And Pharmaceutical Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs); Academic And Research Institutions
• Subsegments:
• 1) By Cell Culture Media: Serum-Free Media; Serum-Based Media; Defined Media; Specialized Media (E.G., For Stem Cells)
• 2) By Cell Culture Sera: Human Serum
• 3) By Cell Culture Supplements: Growth Factors; Cytokines; Peptides
• 4) By Reagents And Buffers: Enzymes (E.G., Trypsin); Ph Buffers; Cryoprotectants
• 5) By Other Raw Materials: Cell-Free DNA; Plasma And Platelet-Rich Plasma (PRP)
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group Ltd.; Sartorius AG; Miltenyi Biotec; Bio-Techne Corporation; STEMCELL Technologies; PromoCell GmbH; AllCells LLC; BioIVT LLC; ACROBiosystems; Sartorius CellGenix GmbH; RoosterBio Inc.; Takara Bio Inc.; Grifols S.A.; Charles River Laboratories; WuXi AppTec; Catalent Inc.; Fujifilm Cellular Dynamics Inc.; Orgenesis Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cell Therapy Human Raw Materials Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cell Therapy Human Raw Materials Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cell Therapy Human Raw Materials Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cell Therapy Human Raw Materials Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Xeno-Free And Human-Derived Raw Materials
  • 4.2.2 Increasing Emphasis On Gmp-Grade And Clinical-Grade Inputs
  • 4.2.3 Growing Standardization Of Human Cell Sourcing And Processing
  • 4.2.4 Expansion Of Raw Material Requirements For Advanced Cell Therapies
  • 4.2.5 Long-Term Supply Agreements For Critical Human Raw Materials

5. Cell Therapy Human Raw Materials Market Analysis Of End Use Industries

• 5.1 Biopharmaceutical Companies
• 5.2 Pharmaceutical Companies
• 5.3 Contract Research Organizations (Cros)
• 5.4 Contract Manufacturing Organizations (Cmos)
• 5.5 Academic And Research Institutions

6. Cell Therapy Human Raw Materials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell Therapy Human Raw Materials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cell Therapy Human Raw Materials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cell Therapy Human Raw Materials Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cell Therapy Human Raw Materials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cell Therapy Human Raw Materials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell Therapy Human Raw Materials Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell Therapy Human Raw Materials Market Segmentation

• 9.1. Global Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
• 9.2. Global Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
• 9.3. Global Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
• 9.4. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Cell Culture Media, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
• 9.5. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Cell Culture Sera, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Serum
• 9.6. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Cell Culture Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Growth Factors, Cytokines, Peptides
• 9.7. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Reagents And Buffers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
• 9.8. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Other Raw Materials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP)

10. Cell Therapy Human Raw Materials Market Regional And Country Analysis

• 10.1. Global Cell Therapy Human Raw Materials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cell Therapy Human Raw Materials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell Therapy Human Raw Materials Market

• 11.1. Asia-Pacific Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell Therapy Human Raw Materials Market

• 12.1. China Cell Therapy Human Raw Materials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell Therapy Human Raw Materials Market

• 13.1. India Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell Therapy Human Raw Materials Market

• 14.1. Japan Cell Therapy Human Raw Materials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell Therapy Human Raw Materials Market

• 15.1. Australia Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell Therapy Human Raw Materials Market

• 16.1. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell Therapy Human Raw Materials Market

• 17.1. South Korea Cell Therapy Human Raw Materials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell Therapy Human Raw Materials Market

• 18.1. Taiwan Cell Therapy Human Raw Materials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell Therapy Human Raw Materials Market

• 19.1. South East Asia Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell Therapy Human Raw Materials Market

• 20.1. Western Europe Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell Therapy Human Raw Materials Market

• 21.1. UK Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell Therapy Human Raw Materials Market

• 22.1. Germany Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell Therapy Human Raw Materials Market

• 23.1. France Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell Therapy Human Raw Materials Market

• 24.1. Italy Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell Therapy Human Raw Materials Market

• 25.1. Spain Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell Therapy Human Raw Materials Market

• 26.1. Eastern Europe Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell Therapy Human Raw Materials Market

• 27.1. Russia Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell Therapy Human Raw Materials Market

• 28.1. North America Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell Therapy Human Raw Materials Market

• 29.1. USA Cell Therapy Human Raw Materials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell Therapy Human Raw Materials Market

• 30.1. Canada Cell Therapy Human Raw Materials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell Therapy Human Raw Materials Market

• 31.1. South America Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell Therapy Human Raw Materials Market

• 32.1. Brazil Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell Therapy Human Raw Materials Market

• 33.1. Middle East Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell Therapy Human Raw Materials Market

• 34.1. Africa Cell Therapy Human Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cell Therapy Human Raw Materials Market, Segmentation By Product, Segmentation By Type Of Cell Therapy, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell Therapy Human Raw Materials Market Regulatory and Investment Landscape

36. Cell Therapy Human Raw Materials Market Competitive Landscape And Company Profiles

• 36.1. Cell Therapy Human Raw Materials Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cell Therapy Human Raw Materials Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cell Therapy Human Raw Materials Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Miltenyi Biotec Overview, Products and Services, Strategy and Financial Analysis

37. Cell Therapy Human Raw Materials Market Other Major And Innovative Companies

• Bio-Techne Corporation, STEMCELL Technologies, PromoCell GmbH, AllCells LLC, BioIVT LLC, ACROBiosystems, Sartorius CellGenix GmbH, RoosterBio Inc., Takara Bio Inc., Grifols S.A., Charles River Laboratories, WuXi AppTec, Catalent Inc., Fujifilm Cellular Dynamics Inc., Orgenesis Inc.

38. Global Cell Therapy Human Raw Materials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell Therapy Human Raw Materials Market

40. Cell Therapy Human Raw Materials Market High Potential Countries, Segments and Strategies

• 40.1 Cell Therapy Human Raw Materials Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cell Therapy Human Raw Materials Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cell Therapy Human Raw Materials Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer